Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for CervoMed (CRVO) over the last 10 years, with Q3 2025 value amounting to -$0.84.

  • CervoMed's EPS (Basic) fell 5272.73% to -$0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.9, marking a year-over-year decrease of 3302.75%. This contributed to the annual value of -$2.02 for FY2024, which is 14606.85% down from last year.
  • As of Q3 2025, CervoMed's EPS (Basic) stood at -$0.84, which was down 5272.73% from -$0.7 recorded in Q2 2025.
  • In the past 5 years, CervoMed's EPS (Basic) ranged from a high of $0.65 in Q3 2023 and a low of -$2.95 during Q4 2022
  • Its 4-year average for EPS (Basic) is -$0.99, with a median of -$0.83 in 2024.
  • Per our database at Business Quant, CervoMed's EPS (Basic) skyrocketed by 13823.53% in 2023 and then crashed by 18461.54% in 2024.
  • CervoMed's EPS (Basic) (Quarter) stood at -$2.95 in 2022, then surged by 67.8% to -$0.95 in 2023, then grew by 12.53% to -$0.83 in 2024, then decreased by 1.09% to -$0.84 in 2025.
  • Its EPS (Basic) stands at -$0.84 for Q3 2025, versus -$0.7 for Q2 2025 and -$0.56 for Q1 2025.